STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke

RATIONALE/AIM: Despite the increasing efficacy of recanalization therapies for acute ischemic stroke, a large number of patients are left with long-term functional impairment, devoid of efficacious treatments. CD34+ cells comprise a subset of bone marrow-derived mononuclear cells with the capacity t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Autores principales: Sargento-Freitas, João, Pereira, Anabela, Gomes, André, Amorim, Paula, Matos, Teresa, Cardoso, Carla M. P., Silva, Fernando, Santo, Gustavo Cordeiro, Nunes, César, Galego, Orlando, Carda, José, Branco, João, Lourenço, Víctor, Cunha, Luís, Ferreira, Lino
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5949561/
https://ncbi.nlm.nih.gov/pubmed/29867719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00302
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares